Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 편욱범 | * |
dc.date.accessioned | 2016-08-28T11:08:11Z | - |
dc.date.available | 2016-08-28T11:08:11Z | - |
dc.date.issued | 2013 | * |
dc.identifier.issn | 0003-3022 | * |
dc.identifier.other | OAK-14018 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/229954 | - |
dc.description.abstract | BACKGROUND: It is unclear whether postoperative B-type natriuretic peptides (i.e., BNP and N-terminal proBNP) can predict cardiovascular complications in noncardiac surgery. METHODS: The authors undertook a systematic review and individual patient data meta-analysis to determine whether postoperative BNPs predict postoperative cardiovascular complications at 30 and 180 days or more. RESULTS: The authors identified 18 eligible studies (n = 2,051). For the primary outcome of 30-day mortality or nonfatal myocardial infarction, BNP of 245 pg/ml had an area under the curve of 0.71 (95% CI, 0.64-0.78), and N-terminal proBNP of 718 pg/ml had an area under the curve of 0.80 (95% CI, 0.77-0.84). These thresholds independently predicted 30-day mortality or nonfatal myocardial infarction (adjusted odds ratio [AOR] 4.5; 95% CI, 2.74-7.4; P < 0.001), mortality (AOR, 4.2; 95% CI, 2.29-7.69; P < 0.001), cardiac mortality (AOR, 9.4; 95% CI, 0.32-254.34; P < 0.001), and cardiac failure (AOR, 18.5; 95% CI, 4.55-75.29; P < 0.001). For greater than or equal to 180-day outcomes, natriuretic peptides independently predicted mortality or nonfatal myocardial infarction (AOR, 3.3; 95% CI, 2.58-4.3; P < 0.001), mortality (AOR, 2.2; 95% CI, 1.67-86; P < 0.001), cardiac mortality (AOR, 2.1; 95% CI, 0.05-1,385.17; P < 0.001), and cardiac failure (AOR, 3.5; 95% CI, 1.0-9.34; P = 0.022). Patients with BNP values of 0-250, greater than 250-400, and greater than 400 pg/ml suffered the primary outcome at a rate of 6.6, 15.7, and 29.5%, respectively. Patients with N-terminal proBNP values of 0-300, greater than 300-900, and greater than 900 pg/ml suffered the primary outcome at a rate of 1.8, 8.7, and 27%, respectively. CONCLUSIONS: Increased postoperative BNPs are independently associated with adverse cardiac events after noncardiac surgery. Copyright © 2013, the American Society of Anesthesiologists, Inc. Lippincott Williams &Wilkins. | * |
dc.language | English | * |
dc.title | Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: Systematic review and individual patient meta-analysis | * |
dc.type | Review | * |
dc.relation.issue | 2 | * |
dc.relation.volume | 119 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 271 | * |
dc.relation.lastpage | 283 | * |
dc.relation.journaltitle | Anesthesiology | * |
dc.identifier.doi | 10.1097/ALN.0b013e31829083f1 | * |
dc.identifier.scopusid | 2-s2.0-84880924940 | * |
dc.author.google | Rodseth R.N. | * |
dc.author.google | Biccard B.M. | * |
dc.author.google | Chu R. | * |
dc.author.google | Lurati Buse G.A. | * |
dc.author.google | Thabane L. | * |
dc.author.google | Bakhai A. | * |
dc.author.google | Bolliger D. | * |
dc.author.google | Cagini L. | * |
dc.author.google | Cahill T.J. | * |
dc.author.google | Cardinale D. | * |
dc.author.google | Chong C.P.W. | * |
dc.author.google | Cnotliwy M. | * |
dc.author.google | Di Somma S. | * |
dc.author.google | Fahrner R. | * |
dc.author.google | Lim W.K. | * |
dc.author.google | Mahla E. | * |
dc.author.google | Le Manach Y. | * |
dc.author.google | Manikandan R. | * |
dc.author.google | Pyun W.B. | * |
dc.author.google | Rajagopalan S. | * |
dc.author.google | Radovic&apos | * |
dc.author.google | M. | * |
dc.author.google | Schutt R.C. | * |
dc.author.google | Sessler D.I. | * |
dc.author.google | Suttie S. | * |
dc.author.google | Vanniyasingam T. | * |
dc.author.google | Waliszek M. | * |
dc.author.google | Devereaux P.J. | * |
dc.contributor.scopusid | 편욱범(6508352922) | * |
dc.date.modifydate | 20240123092816 | * |